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ABSTRACT Over the past decades, drug-resistant Mycobacterium tuberculosis strains
have presented a significant challenge, with inadequate diagnosis of tuberculosis
(TB) cases. Here, we report the draft whole-genome sequence of drug-resistant M.
tuberculosis strain S7, which was isolated from a patient from Tripura, India, who was
diagnosed with pulmonary TB.
The worldwide emergence and spread of tuberculosis (TB) cases resistant to theavailable anti-TB drugs pose serious public health threats. In particular, India
accounts for the greatest number of TB cases, nearly one-fourth of the total global TB
burden, with an equivalent share of drug-resistant TB cases (1, 2).
Here, we report the whole-genome sequence of Mycobacterium tuberculosis strain
S7, which was isolated from a patient from Tripura, India, who was diagnosed with
pulmonary TB. The sputum sample was processed and cultured at 37°C in a myco-
bacterial growth indicator tube (MGIT) with polymyxin B-amphotericin-nalidixic
acid-trimethoprim-azlocillin (PANTA) supplement. The drug susceptibility test (DST)
results revealed resistance to the anti-TB drugs isoniazid (0.1 g/ml) and clofazi-
mine (0.5 g/ml).
Study protocols adopted in this study were approved by the human ethics com-
mittees of the International Centre for Genetic Engineering and Biotechnology (New
Delhi, India) (protocol ICGEB/IEC/2017/07) and Agartala Government Medical College
(Agartala, India) (protocol F.4[6-9]/AGMC/Academic/IEC Committee/2015/8965, dated
25 April 2018). After receiving an informed signed consent form to participate in this
study, subjects were recruited at Agartala Government Medical College.
An aliquot from the MGIT was transferred into 7H9 medium with Middlebrook oleic
acid-albumin-dextrose-catalase (OADC) growth supplement (10%) and grown at 37°C in
a shaking incubator. The genomic DNA was extracted from the exponentially growing
M. tuberculosis S7 culture (optical density at 600 nm, 1.0) following the protocol
reported by Warren et al. (3). Sequencing was performed on a HiSeq 4000 system
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(Illumina, Inc., San Diego, CA, USA) using the TruSeq SBS v3 reagent kit (2  150 bp) for
library preparation. The quality of Illumina raw reads was checked using fastp v0.20.0
(4), which indicated that the sequencing coverage was 100. After filtering, a total of
24,624,392 reads, with 93.44% of bases with a quality score above Q30, were found. The
de novo genome assembly was performed using SPAdes v3.13.2 (5), and the assembly
quality was assessed using QUAST v5.0.2 (6). The assembly comprised 206 contigs (81
contigs of 500 bp), with a total length of 4,401,606 bp, an N50 value of 129,971 bp,
and an average GC content of 65.6%. Raw assembled contigs were aligned against the
reference genome H37Rv (GenBank accession number NC_000962.3) using Mauve
version snapshot 2015-02-13 (7), resulting in a total of 57 locally colinear blocks, 1,089
single-nucleotide polymorphisms, and 179 gaps in the assembly. Genome annotation
was performed using Prokka v1.14.0, with default parameter settings (8). A total of
4,044 coding sequences, 53 tRNAs, and 3 rRNAs were predicted. Default parameters
were used for all software unless otherwise noted.
Species identification and drug resistance prediction were performed with Mykrobe
v0.7.0 (9), and the strain was identified to be of European-American lineage. A predicted
mutation from C to T in the fabG1 gene, at position 1673425 of the reference genome,
was annotated for isoniazid resistance, which confirms our DST results. ResFinder v3.2
(10) predicted two antimicrobial resistance genes, namely, aac(2=)-Ic and erm(37), which
are involved in aminoglycoside and macrolide resistance, respectively. Additionally,
unknown mutations were identified in gyrA (p.E21Q, p.S95T, and p.G668D) and ethR
(p.A9T) genes in M. tuberculosis S7. None of the aforementioned tools used for drug
resistance prediction identified genes responsible for clofazimine resistance. The avail-
ability of high-quality genome data for the M. tuberculosis S7 strain will serve as a
valuable resource for comparative studies on the epidemiology of globally emerging
drug-resistant TB.
Data availability. The raw reads of the whole-genome sequence of M. tuberculosis
S7 were submitted to the SRA under accession number SRR10695721. The GenBank
accession number is WUJD00000000.
ACKNOWLEDGMENT
This work was supported by the Department of Biotechnology, Government of India
(grant BT/PR23238/NER/95/636/2017 to A. Dasgupta, B. Goswami, D. Gupta, A. Das, and
R. K. Nanda).
REFERENCES
1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye
C. 2003. The growing burden of tuberculosis: global trends and inter-
actions with the HIV epidemic. Arch Intern Med 163:1009 –1021. https://
doi.org/10.1001/archinte.163.9.1009.
2. Arinaminpathy N, Batra D, Khaparde S, Vualnam T, Maheshwari N, Sharma
L, Nair SA, Dewan P. 2016. The number of privately treated tuberculosis
cases in India: an estimation from drug sales data. Lancet Infect Dis 16:
1255–1260. https://doi.org/10.1016/S1473-3099(16)30259-6.
3. Warren R, Kock M, Engelke E, Myburgh R, Pittius NG, Victor T, Helden P.
2006. Safe Mycobacterium tuberculosis DNA extraction method that does
not compromise integrity. J Clin Microbiol 44:254 –256. https://doi.org/
10.1128/JCM.44.1.254-256.2006.
4. Chen S, Zhou Y, Chen Y, Gu J. 2018. fastp: an ultra-fast all-in-one FASTQ
preprocessor. Bioinformatics 34:i884 –i890. https://doi.org/10.1093/
bioinformatics/bty560.
5. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS,
Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV,
Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new
genome assembly algorithm and its applications to single-cell sequenc-
ing. J Comput Biol 19:455– 477. https://doi.org/10.1089/cmb.2012.0021.
6. Gurevich A, Saveliev V, Vyahhi N, Tesler G. 2013. QUAST: quality assess-
ment tool for genome assemblies. Bioinformatics 29:1072–1075. https://
doi.org/10.1093/bioinformatics/btt086.
7. Darling AC, Mau B, Blattner FR, Perna NT. 2004. Mauve: multiple align-
ment of conserved genomic sequence with rearrangements. Genome
Res 14:1394 –1403. https://doi.org/10.1101/gr.2289704.
8. Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioin-
formatics 30:2068 –2069. https://doi.org/10.1093/bioinformatics/btu153.
9. Walker TM, Kohl TA, Omar SV, Hedge J, Del Ojo Elias C, Bradley P, Iqbal
Z, Feuerriegel S, Niehaus KE, Wilson DJ, Clifton DA, Kapatai G, Ip CLC,
Bowden R, Drobniewski FA, Allix-Béguec C, Gaudin C, Parkhill J, Diel R,
Supply P, Crook DW, Smith EG, Walker AS, Ismail N, Niemann S, Peto TEA,
Modernizing Medical Microbiology (MMM) Informatics Group. 2015.
Whole-genome sequencing for prediction of Mycobacterium tubercu-
losis drug susceptibility and resistance: a retrospective cohort study.
Lancet Infect Dis 15:1193–1202. https://doi.org/10.1016/S1473-3099
(15)00062-6.
10. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O,
Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial
resistance genes. J Antimicrob Chemother 67:2640 –2644. https://doi
.org/10.1093/jac/dks261.
Meher et al.
Volume 9 Issue 17 e01567-19 mra.asm.org 2
 on S
eptem
ber 30, 2020 at U
niversity of G
roningen
http://m
ra.asm
.org/
D
ow
nloaded from
 
